CANF fundamentals
CAN FITE BIO revenue breakdown overview
CAN FITE BIO revenue for the last year amounted to 2.46 M ILS, the most of which — 2.49 M ILS — came from its highest performing source at the moment, Biopharmaceuticals, the year earlier bringing 2.74 M ILS. The greatest contribution to the revenue figure was made by Israel — last year it brought CAN FITE BIO 2.49 M ILS, and the year before that — 2.74 M ILS.
By source
By country